CD163 and non-small cell lung carcinoma: Furthermore, a recent study by Zheng et al. evaluated the spatial distribution and density of M1- and CD163+ M2-macrophages in non-small cell lung cancer using multiplex immunofluorescence staining and RNA-seq.